COVID-19 患者合并结核病和曲霉菌病：病例报告。

IF 1.3 Q4 MICROBIOLOGY

Iranian Journal of Microbiology Pub Date : 2024-06-01 DOI:10.18502/ijm.v16i3.15800

Elahe Sasani, Sadegh Khodavaisy, Mohammadreza Salehi, Sareh Bagheri-Josheghani, Mahsa Abdorahimi, Seyed Ali Dehghan Manshadi, Alireza Abdollahi, Amir Salami, Marjan Sohrabi, Arezoo Salami Khaneshan

{"title":"COVID-19 患者合并结核病和曲霉菌病：病例报告。","authors":"Elahe Sasani, Sadegh Khodavaisy, Mohammadreza Salehi, Sareh Bagheri-Josheghani, Mahsa Abdorahimi, Seyed Ali Dehghan Manshadi, Alireza Abdollahi, Amir Salami, Marjan Sohrabi, Arezoo Salami Khaneshan","doi":"10.18502/ijm.v16i3.15800","DOIUrl":null,"url":null,"abstract":"Coexisting pulmonary aspergillosis and tuberculosis in a post-COVID-19 patient is rare. Here, we are going to report a case of combined pulmonary aspergillosis and tuberculosis in a 51-year-old female who was previously diagnosed with COVID-19 pneumonia. The patient was treated with voriconazole and anti-tuberculosis agents.","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 3","pages":"428-433"},"PeriodicalIF":1.3000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245357/pdf/","citationCount":"0","resultStr":"{\"title\":\"Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report.\",\"authors\":\"Elahe Sasani, Sadegh Khodavaisy, Mohammadreza Salehi, Sareh Bagheri-Josheghani, Mahsa Abdorahimi, Seyed Ali Dehghan Manshadi, Alireza Abdollahi, Amir Salami, Marjan Sohrabi, Arezoo Salami Khaneshan\",\"doi\":\"10.18502/ijm.v16i3.15800\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Coexisting pulmonary aspergillosis and tuberculosis in a post-COVID-19 patient is rare. Here, we are going to report a case of combined pulmonary aspergillosis and tuberculosis in a 51-year-old female who was previously diagnosed with COVID-19 pneumonia. The patient was treated with voriconazole and anti-tuberculosis agents.\",\"PeriodicalId\":14633,\"journal\":{\"name\":\"Iranian Journal of Microbiology\",\"volume\":\"16 3\",\"pages\":\"428-433\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245357/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iranian Journal of Microbiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/ijm.v16i3.15800\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijm.v16i3.15800","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

COVID-19 后患者同时患有肺曲霉菌病和结核病的情况非常罕见。在此，我们将报告一例合并肺曲霉菌病和肺结核的病例，患者是一名 51 岁的女性，曾被诊断为 COVID-19 肺炎。患者接受了伏立康唑和抗结核药物治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report.

Coexisting pulmonary aspergillosis and tuberculosis in a post-COVID-19 patient is rare. Here, we are going to report a case of combined pulmonary aspergillosis and tuberculosis in a 51-year-old female who was previously diagnosed with COVID-19 pneumonia. The patient was treated with voriconazole and anti-tuberculosis agents.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Iranian Journal of Microbiology MICROBIOLOGY-

CiteScore

2.40

自引率

7.10%

发文量

审稿时长

12 weeks

期刊介绍： The Iranian Journal of Microbiology (IJM) is an international, multi-disciplinary, peer-reviewed journal that provides rapid publication of the most advanced scientific research in the areas of basic and applied research on bacteria and other micro-organisms, including bacteria, viruses, yeasts, fungi, microalgae, and protozoa concerning the development of tools for diagnosis and disease control, epidemiology, antimicrobial agents, clinical microbiology, immunology, Genetics, Genomics and Molecular Biology. Contributions may be in the form of original research papers, review articles, short communications, case reports, technical reports, and letters to the Editor. Research findings must be novel and the original data must be available for review by the Editors, if necessary. Studies that are preliminary, of weak originality or merely descriptive as well as negative results are not appropriate for the journal. Papers considered for publication must be unpublished work (except in an abstract form) that is not under consideration for publication anywhere else, and all co-authors should have agreed to the submission. Manuscripts should be written in English.